SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-019682
Filing Date
2020-02-13
Accepted
2020-02-13 07:05:42
Documents
14
Period of Report
2020-02-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207837-1_8k.htm   iXBRL 8-K 27958
2 EXHIBIT 99.1 tm207837d1_ex99-1.htm EX-99.1 274812
3 GRAPHIC tm207837d1_ex99-1img001.jpg GRAPHIC 12852
  Complete submission text file 0001104659-20-019682.txt   530601

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA irwd-20200213.xsd EX-101.SCH 3204
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20200213_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20200213_pre.xml EX-101.PRE 22722
12 EXTRACTED XBRL INSTANCE DOCUMENT tm207837-1_8k_htm.xml XML 3617
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 20606907
SIC: 2834 Pharmaceutical Preparations